Frontiers in Cardiovascular Medicine | |
Mechanisms of Atherosclerosis Induced by Postprandial Lipemia | |
Longtao Liu1  Chun Gu2  Guijian Liu2  Limin Pan3  Dan Li3  Yixi Zhao3  Yang Wang3  Min Wu3  Shengjie Yang3  Ran Zhao4  | |
[1] Cardiovascular Department, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China;Clinical Laboratory, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China;Comprehensive Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China;Graduate School, Beijing University of Chinese Medicine, Beijing, China; | |
关键词: postprandial lipemia; triglyceride; atherosclerosis; endothelial dysfunction; oxidative stress; inflammation; | |
DOI : 10.3389/fcvm.2021.636947 | |
来源: Frontiers | |
【 摘 要 】
Postprandial lipemia plays an important role in the formation, occurrence, and development of atherosclerosis, and it is closely related to coronary heart disease and other diseases involving endothelial dysfunction, oxidative stress, inflammation, and other mechanisms. Therefore, it has become a focus area for further research. The studies on postprandial lipemia mainly include TG, TRL, VLDL, CM, and remnant cholesterol. Diurnal triglyceride patterns and postprandial hyperlipidemia are very relevant and are now insufficiently covered. The possible mechanisms between postprandial lipemia and cardiovascular disease have been reviewed in this article by referring to relevant literature in recent years. The research progress on the effects of postprandial lipemia on endothelial function, oxidative stress, and inflammation is highlighted. The intervention of postprandial lipemia is discussed. Non-medicinal intervention such as diet and exercise improves postprandial lipemia. As medicinal intervention, statin, fibrate, ezetimibe, omega-3 fatty acids, and niacin have been found to improve postprandial lipid levels. Novel medications such as pemafibrate, PCSK9, and apoCIII inhibitors have been the focus of research in recent years. Gut microbiota is closely related to lipid metabolism, and some studies have indicated that intestinal microorganisms may affect lipid metabolism as environmental factors. Whether intervention of gut microbiota can reduce postprandial lipemia, and therefore against AS, may be worthy of further study.
【 授权许可】
CC BY
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202107137113775ZK.pdf | 850KB | download |